Skip to main content
Arthritis Research & Therapy logoLink to Arthritis Research & Therapy
. 2018 Sep 10;20:206. doi: 10.1186/s13075-018-1700-2

Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

Panagiota Drivelegka 1,, Valgerdur Sigurdardottir 1,2, Anna Svärd 2, Lennart T H Jacobsson 1, Mats Dehlin 1
PMCID: PMC6130065  PMID: 30201030

Correction

Unfortunately, after publication of this article [1], it was noticed that Fig. 2 is incorrect. The correct Fig. 2 can be seen below.

Fig. 2.

Fig. 2

Prevalence rates (95% CIs) of comorbidities in cases and controls for men and women at first gout diagnosis. CI confidence interval, COPD chronic obstructive pulmonary disease, PR prevalence ratio

Reference

  • 1.Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LTH, Dehlin M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res Ther. 2018;20:108. doi: 10.1186/s13075-018-1596-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arthritis Research & Therapy are provided here courtesy of BMC

RESOURCES